---
figid: PMC11278742__medicina-60-01037-g006
pmcid: PMC11278742
image_filename: PMC11278742__medicina-60-01037-g006.jpg
figure_link: /pmc/articles/PMC11278742/figure/F6/
number: Figure 6
figure_title: 'Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy
  of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma:
  A Case Report'
caption: Intracellular MAPK signaling pathway inhibited by the dabrafenib and trametinib
  combination
article_title: 'Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy
  of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma:
  A Case Report'
citation: Charlotte Donz√©, et al. Medicina (Kaunas). 2024 Jul;60(7).
year: '2024'
pub_date: 2024-7-
epub_date: 2024-6-25
doi: 10.3390/medicina60071037
journal_title: Medicina
journa_nlm_ta: Medicina (Kaunas)
publisher_name: MDPI
keywords:
- papillary thyroid carcinoma
- oral anticancer therapy
- pharmacist-led consultations
- dabrafenib
- trametinib
---
